Related Experiment Video
Updated: Jun 23, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Stimuli-Responsive Polypyrrole Hydrogel Integrated into a Mg Battery for Controlled Drug Release
Yueming Mu1, Junze Fan2, Yan Zhou3
1Department of Dermatology and Venereology, The First Hospital of Jilin University, Jilin University, Changchun 130021, China.
Researchers created a self-powered hydrogel drug delivery system. This conductive hydrogel (GPP) acts as a battery cathode, enabling precise, electrically controlled transdermal drug release and motion sensing.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Electrochemistry
Background:
- Stimulus-responsive systems offer precise drug release, but electro-assisted transdermal methods are underdeveloped.
- A research gap exists in integrating electro-assisted drug delivery into transdermal platforms.
Purpose of the Study:
- To develop a self-powered, controllable transdermal drug delivery platform.
- To utilize a conductive hydrogel as a cathode in a magnesium battery for drug delivery.
- To integrate motion sensing capabilities into the drug delivery system.
Main Methods:
- Synthesized a conductive gelatin methacryloyl-polyacrylamide-polypyrrole (GPP) hydrogel via UV cross-linking and in situ polymerization.
- Fabricated a magnesium-GPP battery for self-powered drug delivery.
- Evaluated hydrogel properties, including mechanical strength, electrochemical performance, cytocompatibility, and strain sensing.
- Investigated electrically controlled drug release profiles.
Main Results:
- The GPP hydrogel exhibited a porous structure, high mechanical strength (234% strain), stable electrochemistry, and good cytocompatibility.
- The hydrogel functioned as a sensitive strain sensor (gauge factor: 1.14).
- Drug release was precisely controlled by electrical stimulation, increasing from 0.2 mg/g to 1.6 mg/g within 180 min.
- The integrated Mg-GPP battery enhanced drug delivery 5-fold compared to passive diffusion.
Conclusions:
- The developed self-powered hydrogel platform enables precise, electrically controlled transdermal drug delivery.
- The system integrates drug delivery with motion sensing, offering a novel approach for personalized therapy.
- This technology represents a promising strategy for advanced transdermal therapeutic applications.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed I

